Leadership Change at Alte Oldenburger: What the New CEO Means for the Future

When the CEO of a major health insurer steps down, it marks the end of an era and the beginning of a new strategic chapter. If you are a policyholder, broker, or follow the German private health insurance (PKV) market, this news is for you. The Alte Oldenburger Krankenversicherungsgruppe is preparing for a significant leadership transition. Manfred Schnieders, who has served as Chairman of the Board since 2013, will retire on June 30, 2025. His departure concludes over a decade of leadership where he shaped the group's direction. Effective July 1, 2025, Dr. Dietrich Vieregge, a seasoned insider, will assume the role of CEO, ensuring continuity. Additionally, Stefan Stührmann will be promoted to the board, signaling a blend of experience and fresh internal talent.

The Legacy of Outgoing CEO Manfred Schnieders

Manfred Schnieders leaves behind a substantial legacy. Joining the board in 2012 with responsibility for IT and Sales, he was appointed Chairman just a year later. During his tenure, he oversaw not only the core insurance operations but also capital investment management and key corporate functions. His leadership extended beyond Alte Oldenburger, involving active participation in committees of the VGH Versicherungen group, under which Alte Oldenburger operates. His retirement represents the passing of the torch from a defining figure in the company's modern history.

Meet the New Leadership: Dr. Dietrich Vieregge and Stefan Stührmann

The succession plan emphasizes stability and deep institutional knowledge. The new CEO, Dr. Dietrich Vieregge, is a PhD economist who has been with the broader VGH group since 2002, moving to Alte Oldenburger in 2010. He joined the board in 2017 and has since been responsible for insurance operations. His appointment represents a smooth, internal transition.

Dr. Ulrich Knemeyer, Chairman of the Supervisory Board, expressed confidence: "With Dr. Dietrich Vieregge, we have appointed a Chairman of the Board who, like his predecessor, possesses high professional expertise and lives a cooperative leadership style. We are convinced that the Alte Oldenburger Krankenversicherungsgruppe is also future-proof with the new chairman and his team and look forward to continued cooperation."

Furthermore, Stefan Stührmann (41) will join the board on the same date. His story is one of internal growth: starting his career with an apprenticeship at Alte Oldenburger, he was appointed General Authorized Officer in August 2023. His promotion to the board underscores the company's commitment to developing and rewarding internal talent.

Strategic Continuity in a Competitive Health Insurance Market

This leadership change is noteworthy for its focus on continuity. In the complex and highly regulated German private health insurance sector, where long-term stability is paramount for policyholders, promoting an experienced insider like Dr. Vieregge suggests a commitment to steady, evolutionary growth rather than radical change. His operational background will be crucial in navigating challenges like medical cost inflation, digitalization, and changing customer expectations.

For an American audience, this is similar to a leadership transition at a large US-based health insurance company or a Blue Cross Blue Shield affiliate, where an operational leader with decades of company experience steps into the CEO role to ensure strategic consistency and operational excellence.

What This Means for Policyholders and the Market

For existing and potential customers of Alte Oldenburger, this transition signals stability. The appointment of a CEO deeply familiar with the company's operations and culture is designed to maintain service quality and strategic focus. The simultaneous promotion of a younger leader from within the ranks (Stührmann) also indicates a forward-looking approach to governance and talent development.

As Dr. Dietrich Vieregge prepares to take the helm in July 2025, the key focus will be on steering Alte Oldenburger through the evolving landscape of German healthcare, ensuring it remains a reliable and competitive provider of private health insurance coverage for its members. This planned succession ensures the group is well-positioned for the future, building on a strong legacy while preparing for new challenges.